| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/02/2009 | EP1523372B1 Ghrelin-carrier conjugates |
| 09/02/2009 | EP1478233A4 Method for administering glp-1 molecules |
| 09/02/2009 | EP1418925A4 Bioabsorbable adhesive compunds and compositions |
| 09/02/2009 | EP1411913A4 Antimicrobial nanoemulsion compositions and methods |
| 09/02/2009 | EP1353663B1 Fenofibrate tablets |
| 09/02/2009 | EP1228125A4 Process for making aqueous coated beadlets |
| 09/02/2009 | EP1189645B1 Non-covalent bioconjugates useful for diagnosis and therapy |
| 09/02/2009 | EP1091750B1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
| 09/02/2009 | EP1085908B1 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein |
| 09/02/2009 | EP1005368B1 Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants |
| 09/02/2009 | CN101522221A A process for manufacturing a delivery system for active components as part of an edible composition |
| 09/02/2009 | CN101519495A Interface-cross-linked temperature-sensitive polymer vesicle and use thereof |
| 09/02/2009 | CN101519451A Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof |
| 09/02/2009 | CN101518654A Method for synthesizing novel preparation capable of carrying glucocorticoid to be used as inflammation targeted drug |
| 09/02/2009 | CN101518653A Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/02/2009 | CN101518652A Preparation method of toltrazuril-cyclodextrin inclusion compound |
| 09/02/2009 | CN101518651A Pastille slow-release material and preparation method and application thereof |
| 09/02/2009 | CN101518617A Pharmaceutical composition for improving safety of Shenmai injection and method for preparing same |
| 09/02/2009 | CN101518608A Anti-candidiasis albrican cream and preparation method thereof |
| 09/02/2009 | CN101518598A Tea oral tablet and preparation method thereof |
| 09/02/2009 | CN101518574A Anti-human papilloma virus (anti-HPV) external effervescent tablet and preparation method and application thereof |
| 09/02/2009 | CN101518567A Immediate throat cool buccal dripping pill and detection method thereof |
| 09/02/2009 | CN101518566A Non-oral preparation of guava leaf total flavonoid aglycone, preparation method and application thereof |
| 09/02/2009 | CN101518564A Application of the effective part of astragalus hoangtchy in preparation of anti-inflammatory |
| 09/02/2009 | CN101518563A Non-oral preparation of pachyrhizua angulatus total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518562A Non-oral preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518561A Oral medicinal preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518555A Evening primrose oil dropping pill used for preventing and treating arteriosclerosis and preparation method thereof |
| 09/02/2009 | CN101518554A Oral medicinal preparation of hairy holly root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518552A Pine pollen and cyclodextrin composition, method for preparing same, use of same in preparation of health-care products for resisting fatigue and improving immunity of organisms |
| 09/02/2009 | CN101518551A Ganoderma spore oil fat emulsion and quality control method and application thereof |
| 09/02/2009 | CN101518547A Ophthalmic preparation combination containing deproteinised calf blood extract |
| 09/02/2009 | CN101518530A Stable solid composite medicament of compound penicillin |
| 09/02/2009 | CN101518527A Use of scutellarin in preventing or treating hepatofibrosis and method for preparing micropill thereof |
| 09/02/2009 | CN101518520A Framework-type transdermal patch with dextro ketoprofen accumulated in subcutaneous deep tissues |
| 09/02/2009 | CN101518516A Sodium riboflavin phosphate lyophilized powder for injection and preparation method thereof |
| 09/02/2009 | CN101518515A Cytidine disodium triphosphate freeze-dried powder-injection for injection |
| 09/02/2009 | CN101518514A Econazole nitrate microemulsion aerosol and method for preparing same |
| 09/02/2009 | CN101518513A Cinepazide maleate lipid microspheres preparation and preparation method thereof |
| 09/02/2009 | CN101518512A Calcium gluconate injection and preparation method thereof |
| 09/02/2009 | CN101518511A Method for preparing ophthalmic preparation containing tacrolimus |
| 09/02/2009 | CN101518510A Method for preparing tanshinone micelle |
| 09/02/2009 | CN100535030C Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications |
| 09/02/2009 | CN100535015C Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups |
| 09/02/2009 | CN100534533C Process for preparing original position of nanometer laminated composite material |
| 09/02/2009 | CN100534532C Medicine carrying nanometer particles and preparation method thereof |
| 09/02/2009 | CN100534531C Soluble drug extended release system |
| 09/02/2009 | CN100534530C Vehicle for topical delivery of anti-inflammatory compounds |
| 09/02/2009 | CN100534529C Ordered molecular presentation of antigens, method of preparation and use |
| 09/02/2009 | CN100534431C Niacin sustained release composition for oral administration |
| 09/01/2009 | US7582459 Process for producing a capsular polysaccharide for use in conjugate vaccines |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582311 Comprising hyaluronic acid or sodium hyaluronate dissolved in physiological buffer at concentration of 0.01-3 percent weight per volume and particles comprising first component biologically active agent and second component biocompatible polymeric matrix; use of 23-gauge or smaller bore needle |
| 09/01/2009 | CA2570329C Liposome preparation containing slightly water-soluble camptothecin |
| 09/01/2009 | CA2551975C System for the liberation of an active principle and its use |
| 09/01/2009 | CA2488517C Coated conditioners for use in foods and pharmaceuticals |
| 09/01/2009 | CA2476201C Modified release formulations of at least one form of tramadol |
| 09/01/2009 | CA2467378C Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/01/2009 | CA2460140C Compositions for treatment of common cold |
| 09/01/2009 | CA2448689C Percutaneously absorbable patches |
| 09/01/2009 | CA2417727C Fentanyl composition for nasal administration |
| 09/01/2009 | CA2400804C Stable emulsion compositions of cycloalkene derivatives |
| 09/01/2009 | CA2393344C Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/01/2009 | CA2385867C Sustained release form comprising alpha-lipoic acid or derivatives thereof |
| 09/01/2009 | CA2379147C Percutaneously absorbable preparations |
| 09/01/2009 | CA2370556C Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 09/01/2009 | CA2272540C Anti-oxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 09/01/2009 | CA2238360C Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 09/01/2009 | CA2210812C T-cell affecting peptides |
| 08/27/2009 | WO2009105624A2 Simultaneous delivery of receptors and/or co-receptors for growth factor stability and activity |
| 08/27/2009 | WO2009105548A2 Methods for treating diabetes |
| 08/27/2009 | WO2009105369A1 Sustained release poloxamer containing pharmaceutical compositions |
| 08/27/2009 | WO2009105265A2 Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle |
| 08/27/2009 | WO2009105258A1 Oligomer conjugates of heteropentacyclic nucleosides |
| 08/27/2009 | WO2009105192A2 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax |
| 08/27/2009 | WO2009104838A1 Sustained release solid formulations and methods of manufacturing the same |
| 08/27/2009 | WO2009104739A1 Solid preparation for oral administration |
| 08/27/2009 | WO2009104738A1 Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier |
| 08/27/2009 | WO2009104706A1 Microparticles and pharmaceutical compositions thereof |
| 08/27/2009 | WO2009104649A1 Synthetic glycolipid-containing liposomes |
| 08/27/2009 | WO2009104323A1 Polymer capable of adsorbing acidic water-soluble target substance, and method for production of the polymer |
| 08/27/2009 | WO2009104198A2 Metal conjugates of indole 3- aldehyde azine and its derivatives and uses thereof |
| 08/27/2009 | WO2009104045A1 Ophthalmic gemifloxacin compositions for the treatment of ocular infections |
| 08/27/2009 | WO2009103965A1 Modified linkers |
| 08/27/2009 | WO2009103932A1 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain |
| 08/27/2009 | WO2009103901A2 Pharmaceutical composition containing an n‑phenylpyrazole derivative and glycofurol, use for the preparation of a topical veterinary medicament for combating fleas |
| 08/27/2009 | WO2009103741A2 Use of fsh receptor ligands for diagnosis and therapy of cancer |
| 08/27/2009 | WO2009103209A1 Stable s-(-)- nadifloxacin-l-arginine composition, its preparation method and use |
| 08/27/2009 | WO2009103199A1 A g-csf conjugate modified by water-soluble polymer |
| 08/27/2009 | WO2009103166A1 Treatment of neural diseases or conditions |
| 08/27/2009 | WO2009086296A3 Counter-pressure filtration of proteins |
| 08/27/2009 | WO2009084017A3 Taste-masked orally disintegrating tablets of memantine hydrochloride |
| 08/27/2009 | WO2009083738A3 Rna delivery vehicles |
| 08/27/2009 | WO2009083131A3 Cosmetic, pharmaceutical or dermatological compositions having a high content of water-soluble care components |
| 08/27/2009 | WO2009071860A3 G immunoglobulin used against anthrax toxins |
| 08/27/2009 | WO2009033039A8 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 08/27/2009 | WO2009026328A3 Methods of delivery of agents to leukocytes and endothelial cells |
| 08/27/2009 | WO2007044069A3 Pth formulations and methods of use |